Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 28;1(8):395-9.
doi: 10.1021/ml1001097. eCollection 2010 Nov 11.

Computational Modeling of Kinase Inhibitor Selectivity

Affiliations

Computational Modeling of Kinase Inhibitor Selectivity

Govindan Subramanian et al. ACS Med Chem Lett. .

Abstract

An exhaustive computational exercise on a comprehensive set of 15 therapeutic kinase inhibitors was undertaken to identify as to which compounds hit which kinase off-targets in the human kinome. Although the kinase selectivity propensity of each inhibitor against ∼480 kinase targets is predicted, we compared our predictions to ∼280 kinase targets for which consistent experimental data are available and demonstrate an overall average prediction accuracy and specificity of ∼90%. A comparison of the predictions was extended to an additional ∼60 kinases for sorafenib and sunitinib as new experimental data were reported recently with similar prediction accuracy. The successful predictive capabilities allowed us to propose predictions on the remaining kinome targets in an effort to repurpose known kinase inhibitors to these new kinase targets that could hold therapeutic potential.

Keywords: Kinase selectivity; binding hot spots; binding site signature; computational prediction; kinase conformation; kinase inhibitors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of kinase targets predicted to be active (yellow), classified as experimentally active (Kd ≤ 100 nM; green) and the true positives (blue) are shown for kinase inhibitors bound to the DFG-in (a) or DFG-out (b) kinase conformations.

Similar articles

Cited by

References

    1. Sawa M. Strategies for the design of selective protein kinase inhibitors. Mini Rev. Med. Chem. 2008, 8, 1291–1297. - PubMed
    1. Morphy R. Selectively nonselective kinase inhibition: Striking the right balance. J. Med. Chem. 2010, 53, 1413–1437. - PubMed
    1. Manning G.; Whyte D. B.; Martinez R.; Hunter T.; Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298, 1912–1934. - PubMed
    1. Melnick J. S.; Janes J.; Kim S.; Chang J. Y.; Sipes D. G.; Gunderson D.; Jarnes L.; Matzen J. T.; Garcia M. E.; Hood T. L.; Beigi R.; Xia G.; Harig R. A.; Asatryan H.; Yan S. F.; Zhou Y.; Gu X.-J.; Saadat A.; Zhou V.; King F. J.; Shaw C. M.; Su A. I.; Downs R.; Gray N. S.; Schultz P. G.; Warmuth M.; Caldwell J. S. An efficient rapid system for profiling the cellular activities of molecular libraries. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 3153–3158. - PMC - PubMed
    1. Bain J.; Cummings L.; Elliot M; Shapiro N.; Hastie J.; McLauchian H.; Klevernic I.; Arthur S.; Alessi D.; Cohen P. The selectivity of protein kinase inhibitors; a further update. Biochem. J. 2007, 48, 297–315. - PMC - PubMed